BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30763387)

  • 1. Frequency of reported pain in adult males with muscular dystrophy.
    Jacques MF; Stockley RC; Bostock EI; Smith J; DeGoede CG; Morse CI
    PLoS One; 2019; 14(2):e0212437. PubMed ID: 30763387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between muscle size, strength, and physical activity in adults with muscular dystrophy.
    Jacques MF; Onambele-Pearson GL; Reeves ND; Stebbings GK; Smith J; Morse CI
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1042-1052. PubMed ID: 30338901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
    Srivastava NK; Yadav R; Mukherjee S; Sinha N
    Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Objective and subjective measures of sleep in men with Muscular Dystrophy.
    Morse CI; Onambele-Pearson G; Edwards B; Wong SC; Jacques MF
    PLoS One; 2022; 17(9):e0274970. PubMed ID: 36137167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different profiles of upper limb function in four types of neuromuscular disorders.
    Bergsma A; Janssen MMHP; Geurts ACH; Cup EHC; de Groot IJM
    Neuromuscul Disord; 2017 Dec; 27(12):1115-1122. PubMed ID: 29033278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: In vitro, high-resolution NMR spectroscopy based observation in early phase of the disease.
    Srivastava NK; Yadav R; Mukherjee S; Pal L; Sinha N
    Magn Reson Imaging; 2017 May; 38():163-173. PubMed ID: 28069416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of the functional status of patients with different types of muscular dystrophy.
    Lue YJ; Lin RF; Chen SS; Lu YM
    Kaohsiung J Med Sci; 2009 Jun; 25(6):325-33. PubMed ID: 19560997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral health considerations in muscular dystrophies.
    Balasubramaniam R; Sollecito TP; Stoopler ET
    Spec Care Dentist; 2008; 28(6):243-53. PubMed ID: 19068065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiorespiratory response and physiological determinants of the assisted 6-minute handbike cycle test in adult males with muscular dystrophy.
    Morse CI; Bostock EL; Twiss HM; Kapp LH; Orme P; Jacques MF
    Muscle Nerve; 2018 Sep; 58(3):427-433. PubMed ID: 29669172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decomposition-based quantitative electromyography in the evaluation of muscular dystrophy severity.
    Derry KL; Venance SL; Doherty TJ
    Muscle Nerve; 2012 Apr; 45(4):507-13. PubMed ID: 22431083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.
    Matsuzaka Y; Kishi S; Aoki Y; Komaki H; Oya Y; Takeda S; Hashido K
    Environ Health Prev Med; 2014 Nov; 19(6):452-8. PubMed ID: 25150707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscular Dystrophies.
    Carter JC; Sheehan DW; Prochoroff A; Birnkrant DJ
    Clin Chest Med; 2018 Jun; 39(2):377-389. PubMed ID: 29779596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies.
    García-Giménez JL; García-Trevijano ER; Avilés-Alía AI; Ibañez-Cabellos JS; Bovea-Marco M; Bas T; Pallardó FV; Viña JR; Zaragozá R
    Orphanet J Rare Dis; 2022 Dec; 17(1):450. PubMed ID: 36575500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in adults with muscular dystrophy.
    Jacques MF; Stockley RC; Onambele-Pearson GL; Reeves ND; Stebbings GK; Dawson EA; Groves L; Morse CI
    Health Qual Life Outcomes; 2019 Jul; 17(1):121. PubMed ID: 31307472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic status of patients with muscular dystrophy in early phase of the disease: In vitro, high resolution NMR spectroscopy based metabolomics analysis of serum.
    Srivastava NK; Annarao S; Sinha N
    Life Sci; 2016 Apr; 151():122-129. PubMed ID: 26930370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of conservative non-pharmacological interventions in people with muscular dystrophies: a systematic review and meta-analysis.
    Leone E; Pandyan A; Rogers A; Kulshrestha R; Hill J; Philp F
    J Neurol Neurosurg Psychiatry; 2024 Apr; 95(5):442-453. PubMed ID: 38124127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper extremity function and activity in facioscapulohumeral dystrophy and limb-girdle muscular dystrophies: a systematic review.
    Bergsma A; Cup EH; Geurts AC; de Groot IJ
    Disabil Rehabil; 2015; 37(12):1017-32. PubMed ID: 25098592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone health measured using quantitative ultrasonography in adult males with muscular dystrophy.
    Morse CI; Smith J; Denny A; Tweedale J; Searle ND; Winwood K; Onambele-Pearson GL
    J Musculoskelet Neuronal Interact; 2016 Dec; 16(4):339-347. PubMed ID: 27973386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
    Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
    Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased bone mineral density in adult patients with muscular dystrophy.
    Philippe V; Pruna L; Abdel Fattah M; Pascal V; Kaminsky P
    Joint Bone Spine; 2011 Dec; 78(6):651-2. PubMed ID: 21727019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.